REGENXBIO Inc.
RGNXNasdaqCIK 1590877HealthcareFiscal year ends Dec 31
Reports and events: 180 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1611:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-423376 |
| 2026-09-2320:05 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-399377 |
| 2026-08-2520:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-365287 |
| 2026-08-2421:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-363786 |
| 2026-08-0611:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336725 |
| 2026-08-0611:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336716 |
| 2026-07-2011:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-308342 |
| 2026-06-2911:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-286825 |
| 2026-06-0311:30 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-254590 |
| 2026-05-1411:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-222804 |
| 2026-05-1411:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-222768 |
| 2026-04-1421:00 ET | DEF 14A | Proxy statementPeriod 2026-05-29 | 0001193125-26-155058 |
| 2026-03-2021:15 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-117913 |
| 2026-03-0521:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-094013 |
| 2026-03-0512:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-092566 |
| 2026-02-1002:44 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-043342 |
| 2026-01-2813:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-026139 |
| 2025-11-0612:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268101 |
| 2025-11-0612:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268095 |
| 2025-08-1821:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-109829 |
| 2025-08-0711:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-174953 |
| 2025-08-0711:15 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-174947 |
| 2025-06-0320:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-080986 |
| 2025-05-1920:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-122456 |
| 2025-05-1220:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069237 |
| 2025-05-1220:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069211 |
| 2025-04-0820:15 ET | DEF 14A | Proxy statementPeriod 2025-05-30 | 0000950170-25-052069 |
| 2025-03-1320:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-038770 |
| 2025-03-1320:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-038711 |
| 2025-03-0421:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-045585 |
| 2025-01-1412:08 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005659 |
| 2024-12-0921:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-273467 |
| 2024-11-0621:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122330 |
| 2024-11-0621:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122300 |
| 2024-09-1721:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-107367 |
| 2024-08-0622:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-194111 |
| 2024-08-0120:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-089320 |
| 2024-08-0120:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089278 |
| 2024-06-1300:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-160146 |
| 2024-06-0320:35 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-068050 |
| 2024-05-0820:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055691 |
| 2024-05-0820:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055656 |
| 2024-04-0420:11 ET | DEF 14A | Proxy statementPeriod 2024-05-31 | 0000950170-24-041805 |
| 2024-03-1112:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-064353 |
| 2024-02-2721:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021161 |
| 2024-02-2721:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021130 |
| 2023-11-0821:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061144 |
| 2023-11-0821:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061110 |
| 2023-09-0120:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-227647 |
| 2023-08-0220:15 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-037178 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.